Highly accurate de novo polynucleotide synthesis

US12357959B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12357959-B2
Application numberUS-201916726073-A
CountryUS
Kind codeB2
Filing dateDec 23, 2019
Priority dateDec 26, 2018
Publication dateJul 15, 2025
Grant dateJul 15, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods, systems, compositions, and devices for the manufacturing of high-quality building blocks, such as polynucleotides, are described herein. Processes described herein provide for efficient washing of residual reagents, solvents, or byproducts from previous synthetic steps to allow for the generation of polynucleotides with low error rates. Processes described herein also provide for reduction in deletion rates during chemical nucleic acid synthesis. Further, methods and devices described herein allow for the rapid construction and assembly of large libraries of highly accurate polynucleotides.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of polynucleotide synthesis comprising: providing predetermined sequences for a plurality of preselected polynucleotides; providing a structure comprising a silicon surface; coupling at least one nucleoside to a polynucleotide attached to the silicon surface; washing the silicon surface with a wash solvent, wherein the wash solvent consists essentially of acetone; washing the silicon surface with a capping solution, the capping solution comprising: (i) at least one base; (ii) at least one O-nucleophile selected from a group consisting of acetic acid, formic acid, propionic acid, methoxyacetic acid, phenoxyacetic acid, and water; and (iii) tetrahydrofuran; oxidizing a linkage between the at least one nucleoside and the polynucleotide with an oxidizing solution; and repeating the coupling, washing, capping, and oxidizing steps to synthesize a plurality of polynucleotides. 2. The method of claim 1 , wherein the silicon surface is washed with the wash solvent after the coupling step. 3. The method of claim 1 , wherein the at least one base is selected from the group consisting of pyridine, lutidine, and collidine. 4. The method of claim 1 , wherein a concentration of the at least one O-nucleophile is 0.01-3 M. 5. The method of claim 1 , wherein the capping solution further comprises at least one electrophile, and wherein the at least one electrophile is an anhydride, NHS ester, or acid halide. 6. The method of claim 1 , wherein a concentration of the at least one base is 0.01-3 M. 7. The method of claim 1 , wherein the capping solution comprises the at least one base at about 5-30%, the at least one O-nucleophile at about 5-30%, and the tetrahydrofuran at about 60-90%. 8. The method of claim 1 , wherein the oxidizing solution comprises I 2 or iodine salts, and the I 2 or iodine salts have a greater solubility or increased rate of dissolution in the wash solvent compared to acetonitrile. 9. The method of claim 1 , wherein the capping solution further comprises an activator, wherein the activator is N-methylimidazole or DMAP. 10. The method of claim 9 , wherein concentration of the activator in the capping solution is 0.001-0.05 M. 11. The method of claim 1 , wherein oxidizing the linkage between the at least one nucleoside and the polynucleotide with the oxidizing solution includes depositing the oxidizing solution on the silicon surface and the method further comprises a washing step with the wash solvent after depositing the oxidizing solution on the silicon surface. 12. The method of claim 1 , wherein the polynucleotide or nucleoside comprises DNA or RNA. 13. The method of claim 1 , wherein the structure is a plate, a tape, or a belt, and the silicon surface is functionalized with 3-glycidoxypropyltimethoxysilane. 14. A method for polynucleotide synthesis, comprising: providing predetermined sequences for a plurality of polynucleotides; providing a structure comprising a silicon surface, wherein the silicon surface comprises a plurality of discrete loci configured for polynucleotide synthesis; coupling at least one nucleoside to a polynucleotide attached to the silicon surface, according to the predetermined sequences; oxidizing a linkage between the at least one nucleoside and the polynucleotide with an oxidizing solution; and washing the silicon surface with a wash solvent, wherein the wash solvent consists essentially of acetone. 15. A method for polynucleotide synthesis, the method comprising repeating the steps of claim 14 to synthesize a plurality of polynucleotides, wherein the plurality of polynucleotides are synthesized at an error rate of about 1/5000 or less. 16. The method of claim 14 , wherein the silicon surface is washed with the wash solvent after the at least one nucleoside is coupled to the polynucleotide. 17. The method of claim 16 , further comprising depositing a capping solution on the silicon surface, wherein the capping solution comprises acetyl chloride, acetic anhydride, or an amine base. 18. The method of claim 17 , wherein washing the silicon surface with the wash solvent occurs after oxidizing the linkage and prior to depositing the capping solution, and where the method further comprises, after depositing the capping solution, washing the silicon surface with the wash solvent. 19. The method of claim 14 , wherein the silicon surface is functionalized with 3-glycidoxypropyltrimethoxysilane. 20. The method of claim 14 , wherein the oxidizing solution comprises I 2 or iodine salts, and the I 2 or iodine salts have a greater solubility or increased rate of dissolution in the wash solvent compared to acetonitrile. 21. The method of claim 14 , further comprising depositing a deblocking solution on the silicon surface, wherein the deblocking solution includes a deblocking reagent configured to remove a 5′ OH protecting group. 22. The method of claim 21 , wherein the deblocking solution comprises: acetonitrile, acetone, tetrahydrofuran, or toluene; and an acid.

Assignees

Inventors

Classifications

  • Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals · CPC title

  • monocyclic · CPC title

  • Propionic acid · CPC title

  • Acetic anhydride (ketene C07C49/90) · CPC title

  • Acetic acid (pyroligneous acid C10C; preparation of vinegar C12J) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12357959B2 cover?
Methods, systems, compositions, and devices for the manufacturing of high-quality building blocks, such as polynucleotides, are described herein. Processes described herein provide for efficient washing of residual reagents, solvents, or byproducts from previous synthetic steps to allow for the generation of polynucleotides with low error rates. Processes described herein also provide for reduc…
Who is the assignee on this patent?
Twist Bioscience Corp
What technology area does this patent fall under?
Primary CPC classification C07H21/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).